Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiationviaaltering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals-Reference-Cited by-同舟云学术

Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiationviaaltering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals

Published:2015-03-05 Issue:7 Volume:9 Page:1241-1251
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Dang Qiang,Li Lei,Xie Hongjun,He Dalin,Chen Jiaqi,Song Wenbing,Chang Luke S.,Chang Hong-Chiang,Yeh Shuyuan,Chang Chawnshang

Funder

NIH

George Whipple Professorship Endowment

Taiwan Department of Health Clinical Trial and Research Center of Excellence

China National Program on Key Basic Research

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2015.02.010/fullpdf

Reference44 articles.

1. Neuroendocrine differentiation in prostatic carcinoma;Abrahamsson;The Prostate,1999

2. The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells;Alonzeau;Eur. J. Cancer,2013 Jan

3. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer;Araki;Cancer Res.,2007

4. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors;Chang;Proc. Natl. Acad. Sci. U. S. A.,1988

5. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver;Chang;Oncogene,2014 Jun 19

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplex imaging of localized prostate tumors reveals altered spatial organization of AR-positive cells in the microenvironment;iScience;2024-09

2. Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST;Cell Death Discovery;2024-05-22

3. Deregulated miRNAs in enzalutamide resistant prostate cancer: A comprehensive review of key molecular alterations and clinical outcomes;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

4. Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review;Cancers;2024-02-16

5. DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2;Communications Biology;2024-01-18